Ascendis Pharma A/S Current Trade Receivables
Ascendis Pharma A/S (ASND) had Current Trade Receivables of EUR 141.33 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes › Receivables
ifrs-full:CurrentTradeReceivables · last filed 2026-02-11
- 2025-12-31: Current Trade Receivables 141.33M EUR.
- 2025-09-30: Current Trade Receivables 134.73M EUR.
- 2025-06-30: Current Trade Receivables 110.45M EUR.
- 2025-03-31: Current Trade Receivables 66.69M EUR.
| Period end | Current Trade Receivables |
|---|---|
| 2025-12-31 | 141.33M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 134.73M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 110.45M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 66.69M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 166.28M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 33.10M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 49.16M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 41.09M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 35.87M EUR 20-F · filed 2025-02-12 |
| 2023-09-30 | 26.79M EUR 6-K · filed 2023-11-07 |
| 2023-06-30 | 20.21M EUR 6-K · filed 2023-09-05 |
| 2023-03-31 | 16.12M EUR 6-K · filed 2023-04-27 |
| 2023-01-01 | 11.91M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 11.91M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 6.66M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 4.37M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 5.81M EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 2.20M EUR 20-F · filed 2023-02-16 |
| 2021-09-30 | 533.00K EUR 6-K · filed 2021-11-10 |
| 2021-06-30 | 394.00K EUR 6-K · filed 2021-08-27 |
| 2021-03-31 | 60.00K EUR 6-K · filed 2021-05-27 |
| 2020-12-31 | 387.00K EUR 20-F · filed 2022-03-02 |
| 2020-09-30 | 2.72M EUR 6-K · filed 2020-11-12 |
| 2019-12-31 | 804.00K EUR 20-F · filed 2021-03-10 |
| 2019-03-31 | 4.00K EUR 6-K · filed 2019-05-30 |
| 2018-12-31 | 6.00K EUR 20-F · filed 2020-04-03 |
| 2018-09-30 | 21.00K EUR 6-K · filed 2018-11-28 |
| 2018-06-30 | 17.00K EUR 6-K · filed 2018-08-29 |
| 2018-03-31 | 34.00K EUR 6-K · filed 2018-05-30 |
| 2017-12-31 | 188.00K EUR 20-F · filed 2019-04-03 |
| 2016-12-31 | 287.00K EUR 20-F · filed 2018-03-28 |